1-1090416-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017891.5(C1orf159):c.85G>A(p.Glu29Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,550,490 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017891.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1orf159 | NM_017891.5 | c.85G>A | p.Glu29Lys | missense_variant | 4/10 | ENST00000421241.7 | NP_060361.4 | |
C1orf159 | NM_001330306.2 | c.193G>A | p.Glu65Lys | missense_variant | 6/12 | NP_001317235.1 | ||
C1orf159 | NM_001363525.2 | c.85G>A | p.Glu29Lys | missense_variant | 5/11 | NP_001350454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1orf159 | ENST00000421241.7 | c.85G>A | p.Glu29Lys | missense_variant | 4/10 | 2 | NM_017891.5 | ENSP00000400736 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152218Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000495 AC: 77AN: 155440Hom.: 0 AF XY: 0.000642 AC XY: 53AN XY: 82548
GnomAD4 exome AF: 0.000180 AC: 251AN: 1398154Hom.: 0 Cov.: 31 AF XY: 0.000231 AC XY: 159AN XY: 689608
GnomAD4 genome AF: 0.000184 AC: 28AN: 152336Hom.: 1 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.85G>A (p.E29K) alteration is located in exon 4 (coding exon 2) of the C1orf159 gene. This alteration results from a G to A substitution at nucleotide position 85, causing the glutamic acid (E) at amino acid position 29 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at